Dr. Steven E. Finkelstein M.D., DABR, FACRO, received his M.D. from the University of Michigan in 1997 graduating cum laude eruditions causa. He joined the National Cancer Institute (NCI), National Institutes of Health (NIH) as Clinical Associate in 1999 and completed both Surgical Oncology Fellowship as well as Clinical Immunotherapy Fellowship in 2004. Dr. Finkelstein has been recognized as a Castle Connolly Top Doctor for five years in a row.
Dr. Steven E. Finkelstein M.D., DABR, FACRO, received his M.D. from the University of Michigan in 1997 graduating cum laude eruditions causa. He joined the National Cancer Institute (NCI), National Institutes of Health (NIH) as Clinical Associate in 1999 and completed both Surgical Oncology Fellowship as well as Clinical Immunotherapy Fellowship in 2004. Dr. Finkelstein has been recognized as a Castle Connolly Top Doctor for five years in a row.
The reviews listed below were collected independently of Associated Medical Professionals through rater8. Each review represents an authentic and verified patient experience.
Dr. Finkelstein is a good physician and could be even better if he spent more time following up on his patients by listening and guiding instead of just shaking their hand. His nursing staff is excellent and does most of the work. However, if there is a problem, Dr. Finkelstein is excellent at referring the patient to the proper doctor who can resolve the issue.
Jul-2025
The doctor gave me a more realistic perspective of where I’m at in my treatment journey. He spent almost an hour with me discussing his concerns of the data he was reviewing. He provided a treatment recommendation to further assess my needs and the treatment plan that will follow. His delivery was comforting, and reassuring. I left the consultation feeling better about treating this cancer once and for all.
Jun-2025
Although I’m just a couple of months into my treatment Dr Finkelstein has been great
Jun-2025
Very informative. Like his style.
Jun-2025
Did not disclose how long it would take to complete treatment. Currently it has been 6 months and radiation still not started. I assume Surgery option would likely be faster
Jun-2025
Thoroughly explained everything about my prostrate cancer and my up coming treatment
Jun-2025
He is the most knowledgeable, entertaining and energetic doctor I’ve ever had.
May-2025
Consummate professional. A leader in his field.
May-2025
#1
May-2025
Top of his craft
May-2025
Read More
AMP: Syracuse, NY
1226 East Water Street Syracuse, NY 13210
Dr. Steven E. Finkelstein M.D., DABR, FACRO, received his M.D. from the University of Michigan in 1997 graduating cum laude eruditions causa. He joined the National Cancer Institute (NCI), National Institutes of Health (NIH) as Clinical Associate in 1999 and completed both Surgical Oncology Fellowship as well as Clinical Immunotherapy Fellowship in 2004. Following completion of an additional radiation oncology residency, Dr. Finkelstein was selected as Chief Resident in Radiation Oncology at Moffitt Cancer Center/University of South Florida. In 2011, he was recruited to join the 21C Translational Research Consortium (TRC) and was appointed its National Director. In 2014, he was promoted to 21C Chief Science Officer. In 2017, he returned to Florida to serve as Cancer Director of Bay Regional Cancer Center at AUI. In 2019, Dr. Finkelstein joined the US Oncology Network at Florida Cancer Affiliates to continue advancing patient access to novel, advanced cancer care.
Dr. Finkelstein has a special interest in the study and patient care and research of a variety of cancers, using radiation driven, and personalized systemic therapy. Accordingly, he holds three International patents in the field of cutting edge technologies.
Dr. Finkelstein has given national and international lectures, published numerous professional journal articles and written book chapters, resulting in over 11,000 literature citations with an H-Index of 42. Additionally, he is renowned in bladder, kidney and testicular cancer as well as lung, breast and skin cancers which he also treats at A.M.P. He also serves on the editorial board of key international journals, including the American Society of Clinical Oncology (ASCO) as the ASCO Associate Editor for Immunotherapy.
For these contributions to patients, Dr. Finkelstein was one of the youngest physicians to receive accelerated fellowship in the American College of Radiation Oncology (ACRO) in 2017 and elected to the ACRO Board of Chancellors and Chair of Education in 2018.
Dr. Finkelstein has been recognized as a Castle Connolly Top Doctor for five years in a row.
Dr. Finkelstein is a good physician and could be even better if he spent more time following up on his patients by listening and guiding instead of just shaking their hand. His nursing staff is excellent and does most of the work. However, if there is a problem, Dr. Finkelstein is excellent at referring the patient to the proper doctor who can resolve the issue.
The doctor gave me a more realistic perspective of where I’m at in my treatment journey. He spent almost an hour with me discussing his concerns of the data he was reviewing. He provided a treatment recommendation to further assess my needs and the treatment plan that will follow. His delivery was comforting, and reassuring. I left the consultation feeling better about treating this cancer once and for all.
Although I’m just a couple of months into my treatment Dr Finkelstein has been great
Very informative. Like his style.
Did not disclose how long it would take to complete treatment. Currently it has been 6 months and radiation still not started. I assume Surgery option would likely be faster
Thoroughly explained everything about my prostrate cancer and my up coming treatment
He is the most knowledgeable, entertaining and energetic doctor I’ve ever had.
Consummate professional. A leader in his field.
#1
Top of his craft